Jennifer Deane
Physician Assistant · Burlington, MANPI 1801107446
Payments from drug & device makers
Across 172 payments — averaging $24.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$1K
- E.r. Squibb & Sons, L.L.C.$397
- UCB, Inc.$332
- Novartis$195
- Galderma Laboratories, L.p.$177
- plus $625 from 14 others
What the payments were for
- Food & beverage$3,94995%
- Education$2105%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 63 | $1,388 |
| Johnson & Johnson | 31 | $1,045 |
| E.r. Squibb & Sons, L.L.C. | 17 | $397 |
| UCB, Inc. | 14 | $332 |
| Novartis | 8 | $195 |
| Galderma Laboratories, L.p. | 11 | $177 |
| Janssen Scientific Affairs, LLC | 1 | $114 |
| Sanofi | 4 | $110 |
| Organon | 9 | $105 |
| Lilly USA, LLC | 3 | $69 |
| LEO Pharma Inc. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Sun Pharmaceutical Industries Inc. | 1 | $26 |
| Amgen | 1 | $23 |
| Boehringer Ingelheim | 1 | $22 |
| Pfizer | 1 | $22 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $20 |
| Botanix SB Inc | 1 | $18 |
| Incyte Corporation | 1 | $18 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,159 in reported general payments places this provider in the 95th percentile of 3,507 physician assistant providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 43 | $168,506 |
| Humira(Cf) PenAdalimumab | 12 | $79,749 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $79,333 |
| Dupixent SyringeDupilumab | 22 | $79,162 |
| Tacrolimus | 24 | $5,114 |
| Betamethasone Diprop AugmentedBetamethasone Dipropionate | 26 | $4,189 |
| Betamethasone Dipropionate | 47 | $3,267 |
| Triamcinolone Acetonide | 108 | $1,854 |
| Ketoconazole | 64 | $1,670 |
| Azelaic Acid | 15 | $1,346 |
| Tretinoin | 11 | $1,199 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 14 | $1,055 |
| Clindamycin Phosphate | 27 | $907 |
| Doxycycline Monohydrate | 34 | $675 |
| Nystatin | 32 | $661 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Burlington
- Christopher MasseyWilbraham$190K
- Lizabeth O ConnorEverett$182K
- Kimberly ComeauSwampscott$120K
- Stacey PanasciSpringfield$113K
- Jason RandWaltham$99K
- Karen ChunEast Boston$70K
- David PeckhamQuincy$61K
- Leslie SmithSpringfield$49K
- Andrea MilliganBoston$46K
- Lauren RousseauBoston$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.